Skip to content

Clinical trials

Lung Diseases, Obstructive trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Obstructive Country / region: United States Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20033
20056
20071
20081
20093
20101
20111
20123
20133
20148
20154
20167
20172
20183
20201
20211
20223
20235
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50
Recruiting5
Terminated5
Active, not recruiting1
Withdrawn1
Unknown status1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca18
University of Michigan5
Columbia University3
Novartis Pharmaceuticals3
Albert Einstein College of Medicine2
Grifols Therapeutics LLC2
Mayo Clinic2
National Heart, Lung, and Blood Institute (NHLBI)2
University of California, San Francisco2
University of Chicago2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Obstructive64
Lung Diseases37
Respiratory Tract Diseases31
Asthma27
Pulmonary Disease, Chronic Obstructive26
Bronchial Diseases25
Immune System Diseases9
Hypersensitivity7
Respiratory Hypersensitivity7
Hypersensitivity, Immediate5

Trials

Showing 26 to 50 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.